Literature DB >> 28192581

Necrotizing Pneumonia.

Elitsa V Nicolaou, Allison H Bartlett.   

Abstract

Necrotizing pneumonia refers to the development of necrosis, liquefication, and cavitation of the lung parenchyma from an infectious pathogen. Nearly 4% of all community-acquired pneumonias are necrotizing, although studies retrospectively evaluating the incidence have found it to be increasing during the past 20 years. Common presenting symptoms include fever, tachypnea, and cough, and most of those afflicted also develop complications such as parapneumonic effusions, empyemas, or bronchopleural fistulae. When compared to age-matched controls with parapneumonic effusions or severe pneumonias without a necrotizing component, those with necrotizing pneumonia have been shown to have more elevated white blood cell counts and inflammatory markers that take longer to normalize, a longer duration of symptoms despite initiation of therapy, and a longer hospital stay. Despite the high incidence of complications during the acute phase of illness, the overall prognosis of necrotizing pneumonia has been shown to be promising, with nearly all children surviving the illness. [Pediatr Ann. 2017;46(2):e65-e68.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28192581     DOI: 10.3928/19382359-20170120-02

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  6 in total

1.  ARHGAP24 ameliorates inflammatory response through inactivating Rac1/Akt/NF-κB pathway in acute pneumonia model of rat.

Authors:  Huailian Liu; Wangpeng Wang; Wenyi Shen; Lili Wang; Yangsong Zuo
Journal:  Ann Transl Med       Date:  2020-10

2.  Necrotizing Pneumonia Caused by Chromobacterium violaceum: Report of a Rare Human Pathogen Causing Disease in an Immunodeficient Child.

Authors:  Alean A Frawley; Lauren Powell; John R McQuiston; Christopher A Gulvik; Rodolfo E Bégué
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

3.  Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China.

Authors:  Kang Cai; Yizhong Wang; Zhongqin Guo; Xiaonan Xu; Huajun Li; Qingli Zhang
Journal:  Infect Drug Resist       Date:  2018-11-26       Impact factor: 4.003

4.  12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant Staphylococcus aureus.

Authors:  Enrique Chacon-Cruz; Rosa Maria Rivas-Landeros; Maria Luisa Volker-Soberanes; Erika Zoe Lopatynsky-Reyes; Chandra Becka; Jorge Arturo Alvelais-Palacios
Journal:  Ther Adv Infect Dis       Date:  2019-04-03

5.  Clinical value of blood related indexes in the diagnosis of bacterial infectious pneumonia in children.

Authors:  Hai-Han Zheng; Yun Xiang; Yan Wang; Qing-Song Zhao; Rui Fang; Rui Dai
Journal:  Transl Pediatr       Date:  2022-01

6.  Necrotizing pneumonia with bronchopleural fistula as an uncommon complication of pneumonia in children: a case report.

Authors:  Damayanti Sekarsari; Syeida Handoyo; Mohamad Yanuar Amal; Primadea Kharismarini
Journal:  Radiol Case Rep       Date:  2021-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.